Significant Contract Modifications ($10M+) — August 21, 2026

CACI secured a $674M cost-plus-fixed-fee delivery order from GSA for IT and telecom services under the Communication and Information Technology Services III program, with base plus all options totaling $722.6M. Cost-plus pricing reduces margin risk, and full-and-open competition signals technical merit.

Teledyne Brown's $372M NASA ISS mission support contract ended in December 2022, but only $151.3M was actually outlayed, indicating under-execution or delayed spending. No follow-on contract is visible in this data.

BARDA (HHS) awarded a $264M cost-plus-fixed-fee contract to the Albert B. Sabin Vaccine Institute for Marburg virus advanced R&D, with total potential value of $1.04B over 10 years. This signals sustained biodefense investment, though the recipient is a nonprofit, limiting direct equity exposure.

CACI's $674M GSA contract has a total outlayed amount of -$414,919, which is unusual and may indicate accounting credits or early-stage performance. This could signal cash flow timing issues or contract adjustments.

Highrise Consulting's $139M NIH IT delivery order has $89.6M already outlayed (65% of total obligation), indicating strong execution and recurring revenue visibility through September 2027.

CACI's $674M GSA contract shows a negative net outlay of -$415K, which may indicate accounting adjustments or early-stage performance issues. This requires monitoring in future earnings calls.

Teledyne Brown's $372M NASA ISS contract ended in December 2022 with only $151M outlayed (41%), suggesting potential budget under-execution or program delays. No follow-on contract is visible.

The aggregate is heavily civilian-focused (5 of 6 contracts) with only one defense-related award ($6K Lockheed Martin DHS contract). This limits exposure to defense budget tailwinds from NDAA priorities.

HSGS-AMERESCO's $149M VA energy savings contract is a Service-Disabled Veteran-Owned Small Business set-aside, which limits competition but may cap scalability and margin expansion.

CACI's $674M GSA IT services award through full-and-open competition strengthens its position in federal IT modernization. The cost-plus pricing provides low-risk revenue visibility through 2024.

BARDA's $264M Marburg virus R&D contract (potential $1.04B total) signals sustained biodefense investment. While the prime is a nonprofit, subcontractors in vaccine development and biologics manufacturing could benefit.

Highrise Consulting's $139M NIH IT contract with 65% utilization suggests strong execution and potential for follow-on task orders. The cloud computing focus aligns with federal digital modernization priorities.

Two contracts totaling $813M (CACI $674M GSA IT services and Highrise Consulting $139M NIH cloud support) demonstrate sustained government investment in IT infrastructure and cloud migration, particularly at civilian agencies.

BARDA's $264M Marburg virus R&D contract (potential $1.04B total) highlights continued government commitment to advanced R&D for high-threat pathogens, despite the recipient being a nonprofit.

Teledyne Brown's $372M NASA ISS contract ended with only $151M outlayed (41%), suggesting potential budget under-execution or program delays in manned spaceflight support.

{"entity" => "CACI International Inc.", "reason" => "Negative net outlay (-$415K) on $674M GSA contract requires explanation; contract ends May 2024, creating recompete risk.", "trigger" => "CACI quarterly earnings calls for contract profitability updates; GSA contract modification announcements"}

{"entity" => "Teledyne Technologies", "reason" => "NASA ISS contract expired with only 41% outlayed; no follow-on visible in this data.", "trigger" => "NASA ISS follow-on contract awards; Teledyne Q3/Q4 earnings for space segment revenue"}

{"entity" => "Biodefense Sector", "reason" => "BARDA's $264M Marburg virus contract has potential $1.04B total value; option exercises will determine actual revenue.", "trigger" => "BARDA option exercise announcements through 2036; HHS budget appropriations"}

{"entity" => "Highrise Consulting Inc.", "reason" => "NIH IT contract shows 65% utilization, indicating strong execution; additional task orders could expand revenue.", "trigger" => "NIH IT task order awards through September 2027"}